Answer
Tafamidis meglumine should be discontinued in patients who undergo liver transplantation because no data are available regarding its use after liver transplantation.
Sources for this answer
- Vyndaqel 20 mg soft capsulesPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 18Document updated
Sources checked